5 Speciality Chemical Stocks with Strong Growth Plans for the Next 3 Years

India's speciality chemicals sector is expected to reach US$ 64 billion (bn) by 2025, driven by growing demand from the automotive, pharmaceutical, agriculture, and construction industries.

The speciality chemical sector accounts for 47% of the nation's domestic chemical market and is expected to expand at a CAGR of nearly 11% over the next five years.

Rising urbanisation, government initiatives supporting manufacturing, and India's position as a key supplier in global supply chains are fuelling this growth trajectory.

The sector benefits from raw material availability, a skilled workforce, and an increasing focus on research and development.

Companies are investing heavily in capacity expansion and technological upgrades to capture emerging opportunities in high-value speciality segments.

In this editorial, we discuss 5 speciality chemical stocks with strong growth plans.

#1 Pidilite Industries

Pidilite Industries ltd, incorporated in 1960, is a pioneer in India's speciality chemical sector.

The company operates through two primary segments: Branded Consumer & Bazar (C&B) and Business to Business (B&B).

The C&B segment targets carpenters, painters, and households, with products like adhesives, sealants, art materials, and construction chemicals, with the flagship Fevicol brand.

The B2B segment produces industrial adhesives, synthetic resins, organic pigments, and construction sectors, catering to industrial users across packaging, textiles, paints, and construction chemicals.

Growth Plans

• Category Expansion: Initiatives targeting Rs 1 bn revenue within three years of national rollout, with growth categories performing 2-4x faster than core segments.
• B2B Segment Acceleration: Maintaining low-to-mid teens growth rate driven by construction upswing, cement consumption growth, and consistent double-digit volume growth.
• Rural Market Penetration: Leveraging a 2-3-year runway for strong growth in rural and semi-urban India through Pidilite Ki Duniya and Dr Fixit Centres expansion strategies.
• New Venture development: Expanding Hasiha Paints beyond five pilot states and developing UnoFin for larger projects. Building electronics, EV, and semiconductor industry partnerships.
• Sustainable Growth: Maintaining a 3-5% advertising spend ratio, targeting C&B segment CAGR of 12.7% and B2B segment CAGR of 11.6% over the next five years.

Financial Performance

Pidilite Industries Financial Snapshot (FY21-25)

Source: Company Annual Report

Pidilite's financial trajectory over the recent years reflects both growth challenges and recovery.

Initial revenue expansion was accomplished by margin compression due to high material costs, leading to slower profitability growth despite strong sales increases.

The company faced headwinds from uncertain global economic conditions and rising input costs that squeezed operating margins.

However, recent periods demonstrate significant operational improvement through effective cost management and favourable pricing strategies.

The company successfully navigated market volatility by optimising operations, leading to substantial margin expansion and accelerated profit growth.

Strategic business exits, including divesting from the Americas, and strong performance in the B2B segment contributed to improved profitability and sustained margin enhancement across both domestic and international operations.

#2 PI Industries

PI Industries ltd was founded in 1946 as Mewar Oil & General Mills. It operates as an integrated agrisciences company advancing global food security and environmental sustainability.

The company spans the entire life sciences value chain through research and development, custom synthesis and manufacturing, and co-marketing distribution across over 40 countries.

The core business centres on agrochemicals, providing innovative and sustainable solutions to enhance crop productivity.

Strategic diversification includes pharma contract research and manufacturing services, biologics development, and electronic chemicals collaboration with global partners.

PI Industries generates revenue primarily from selling active ingredients, intermediates, and formulations, supplemented by service revenue.

Growth Plans

• Product Innovation: PI Industries plans to maintain its momentum by launching 8-10 new products each year, backed by a healthy pipeline of over 20 products currently under development and registration.
• Business Diversification: The company is aggressively expanding beyond agrochemicals, aiming to triple pharma revenues in 3-4 years while growing the biologicals business five-fold to reach Rs 12 bn annually.
• Manufacturing Capacity Boost: Two new multi-product plants will be commissioned by FY27, with a capex of Rs 7-9 bn to meet growing demand across segments.
• Revenue Growth Focus: Management targets 15% revenue growth with domestic business expected to outperform the industry average with 15-20% growth.

Financial Performance

PI Industries Financial Snapshot (FY21-25)

Source: Company Annual Report

PI Industries experienced strong revenue growth driven by export expansion and successful product diversification.

Initial margin pressure stemmed from rising fuel costs, utility expenses, and strategic investment spending related to business expansion.

The company demonstrated resilience during times of global headwinds and inventory destocking cycles through consistent above-industry performance.

Significant margin improvements reflected operational efficiency gains, favourable product mix shifts towards higher-value offerings, and enhanced gross margin expansion from value-added products.

However, recent profit pressure emerged from substantially higher effective tax rates due to the phasing out of Special Economic Zone exemptions. This has offset strong operational performance.

The company's diversification into biologics and pharma segments provided new growth avenues, while export market strength compensated for domestic pricing challenges and volume fluctuations.

#3 Sumitomo Chemical India

Sumitomo Chemical India ltd (SCIL), incorporated in 2000 and listed in 2018, operates as a subsidiary of Japan's Sumitomo Chemical Company. It focuses on producing diverse agrochemical solutions.

SCIL manufactures and sells household insecticides, agricultural pesticides, including insecticides, fungicides, and herbicides, public health insecticides, and animal nutrition products.

Operating five manufacturing facilities across India, the company maintains over 900 stock-keeping units and exports to more than 50 countries.

Revenue streams are diversified across product categories, with insecticides contributing 40%, herbicides 21%, and other segments including fungicides and animal nutrition products.

Geographic revenue split shows 78% domestic sales and 22% exports, primarily to Brazil and Japan.

For FY25, business segments are divided between branded products (77%) and bulk products (23%), demonstrating strong market positioning across speciality and generic agrochemical solutions.

Growth Plans

• Dahej Manufacturing Hub: The company is building a manufacturing facility at Dahej that will house multiple plants for different products, with production expected to start rolling out between 2027 and 2029.
• Product Launch Acceleration: SCIL plans to introduce 20 new products in the coming year, including recently registered Lentigo and Excalia Max, spanning herbicides, fungicides, and biorational solutions.
• Export Business Expansion: The new Dahej facility will serve as a key export hub, helping the company significantly grow its international presence over the next few years.
• Domestic Market Growth: The company aims to deepen its footprint in India by increasing sales volumes of current products while launching new patented and generic solutions.
• Technology and Sustainability Focus: SCIL is investing in green energy initiatives, digital transformation for better operations, and exploring opportunities in the semiconductor space through its Japanese parent company.

Financial Performance

Sumitomo Chemical India Financial Snapshot (FY21-25)

Source: Company Annual Report

SCIL's financial trajectory reflects cyclical industry dynamics and recovery patterns.

The company experienced strong growth momentum through consistent volume expansion and export market development, driven by a good domestic franchise and effective channel engagement.

However, it faced a setback due to challenging pricing environment and market downturns that impacted both domestic and export sales.

The recent recovery demonstrates operational resilience through volume-led growth despite pricing pressure. Margin improvement resulted from normalised sales operations, and effective cost management.

Return ratios fluctuated due to profit reinvestment expanding the net worth, reflecting conservative financial management and sustainable business practices.

#4 Vinati Organics

Vinati Organics ltd (VOL) has evolved from a single-product manufacturer into a global speciality chemicals company offering over 30 diverse solutions to more than 40 countries.

The company operates 3 manufacturing facilities in Maharashtra, focusing on speciality organic intermediaries and monomers.

Key products include ATBS (60-65% global market share), IBB (65% market share), butylphenol, antioxidants, and customised solutions.

Through its subsidiary Veeral Organics Pvt Ltd, VOL manufactures niche speciality chemicals for various applications.

The company generates 56% revenue from exports and leverages 33 MW solar capacity for sustainable operations.

Growth Plans

• Revenue Growth Target: The company is aiming for a 20% CAGR over the next 3 years, primarily driven by ATBS expansion, antioxidants scaling up, and new product launches.
• ATBS Capacity Expansion: Two-phase capacity expansion will boost ATBS production by 25-30% starting June 2025, with the second phase following a year later.
• Antioxidant Business Scaling: Plans to increase antioxidant plant capacity utilisation to 90% over 2 years.
• New Product Development: VOPL subsidiary will introduce new products in FY26 for polymerisation inhibitors, oilfield resins, flavours, fragrances, and pharmaceutical applications, expecting Rs 1+ bn revenue.
• Strategic Investment: The company has allocated Rs 3.5-4 bn for FY26 to fund expansion projects, R&D initiatives, and operational efficiency improvements while completing ongoing Rs 8 bn investment projects.

Financial Performance

Vinati Organics Financial Snapshot (FY21-25)

Source: Company Annual Report

Vinati Organics experienced strong initial growth driven by volume performance across product segments, though this came with margin compression due to scaling challenges.

The company maintained its momentum through high EBITDA growth and operational improvements that restored margin stability.

However, a challenging market environment subsequently impacted performance, leading to revenue decline and reduced profitability across all metrics. The downturn reflects difficult market conditions that pressured both volumes and margins.

Recovery emerged through a strong volume uptick, particularly in the ATBS segment, supported by disciplined cost management and enhanced operational efficiency.

The rebound demonstrated the company's ability to navigate market cycles through effective operational strategies, product mix optimisation, and cost control measures, ultimately delivering improved margins and profit growth across the speciality chemicals portfolio.

#5 Epigral

Epigral ltd was incorporated in 2007 as Meghmani Finehem Ltd. and rebranded in 2023. It's a leading manufacturer of Chlor-Alkali and its derivatives.

The company began Chlor-Alkali operations in 2009 and became publicly listed in 2021 after demerging from Mehmani Organics Ltd.

With a state-of-the-art facility in Dahej, Gujarat, Epigral manufactures diverse products including CPVC Resin, CPVC Compound, Chlorotoluenes, Epichlorohydrin, Chloromethanes, Hydrogen Peroxide, and Caustic Soda.

These chemicals serve over 15 downstream industries, including CPVC pipes, paints, pharmaceuticals, and agrochemicals.

The company is strategically transitioning toward derivatives and speciality chemicals, with an R&D centre in Ahmedabad supporting product development.

Revenue primarily comes from Chlor-Alkali and derivative sales, supplemented by by-products, export incentives, and scrap sales.

Growth Plans

• Massive Capacity Expansion: The company is doubling CPVC resin capacity to 150,000 TPA and Epichlorohydrin to 100,000 TPA, creating the world's largest and India's largest capacities, respectively, by FY27.
• New Chemistry Development: Commissioning India's first Chlorotoluenes manufacturing facility within months, with revenue expected from H2 FY26 and optimal utilisation by FY27.
• Capital Investment program: Executing Rs 7.8 bn multi-year capex until FY27, including Rs 4.5 bn for FY26, focusing on high-margin derivatives and speciality chemicals.
• Revenue Mix Transformation: Targeting over 70% revenue from derivatives and speciality chemicals by FY27, 15-20% CAGR growth, and a sustainable 25% EBITDA margin through value-added products.
• Infrastructure Expansion: Developing a new chemistry value chain on recently acquired 100-acre land for next decade growth, while achieving 90% chlorine integration through operational optimisation projects.

Financial Performance

Epigral Financial Snapshot (FY21-25)

Source: Company Annual Report

Epigral's financial journey reflects the cyclical nature of the chemical industry and strategic transformation initiatives.

Initial strong growth was driven by high product realisations, volume expansion from previous capital investments, and effective cost management despite inflationary pressure on raw materials.

The company faced significant challenges during a difficult market environment characterised by volatile macroeconomics, subdued demand, and drastically reduced realisations across all products, despite achieving volume growth.

Recovery emerged through a strategic focus on derivatives and speciality chemicals, improved product mix optimisation, and better capacity utilisation.

Conclusion

India's speciality chemicals sector is positioned for sustained growth, with leading speciality chemicals companies executing capacity expansions, product diversification, and strategic transformations into high-value segments.

These opportunities present compelling potential, but investors should carefully evaluate company fundamentals, market cycles, corporate governance and their risk tolerance before making any investment decisions.

Disclaimer: This article is for information purposes only. It is not a stock recommendation and should not be treated as such. Learn more about our recommendation services here...